Altimmune, Inc. Common Stock (ALT) is a publicly traded Healthcare sector company. As of November 9, 2026, ALT trades at $2.14 with a market cap of $404.60M and a P/E ratio of -3.58. ALT moved +3.61% today. Year to date, ALT is -40.74%; over the trailing twelve months it is -47.21%. Its 52-week range spans $1.91 to $7.73. Analyst consensus is strong buy with an average price target of $21.25. Rallies surfaces ALT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover ALT: 0 strong buy, 4 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $21.25.
| Metric | Value |
|---|---|
| Price | $2.14 |
| Market Cap | $404.60M |
| P/E Ratio | -3.58 |
| EPS | $-0.77 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.73 |
| 52-Week Low | $1.91 |
| Volume | 2.64M |
| Avg Volume | 0 |
| Revenue (TTM) | $31.00K |
| Net Income | $-91.76M |
| Gross Margin | 0.00% |
5 analysts cover ALT: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $21.25.